secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K/A
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0000950170-24-084023
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 9.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics to effect 1-for-10 reverse stock split effective July 17, 2024
--------------------------------------------------------------------------------

- Reverse split at 1-for-10 ratio; effective 5:00 p.m. Eastern on July 17, 2024.
- Stock will trade split-adjusted on Nasdaq under symbol 'TCRT' starting July 18, 2024 with new CUSIP 98973P309.
- Stockholder approval obtained at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.
- Equiniti Trust Company appointed as exchange agent to handle share conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024084023/0000950170-24-084023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024084023/tcrt-20240716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-084023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer